Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Solid Biosciences update call. [Operator instructions] Please be advised that today s conference is being recorded. I would now like to hand the conference over to your speaker today, Mr. Tim Palmer, corporate communications manager at Solid Biosciences.
Sir, you may begin.
Corporate Communications Manager
Good morning. Thank you, operator. Before we get started, I would like to remind everyone that during this conference call, we may make forward-looking statements, including statements about the company s financial results, financial guidance, future business strategies and operations and product development and regulatory progress, including statements about the ongoing IGNITE DMD clinical trial. Actual results could differ materially from those discussed in these forward-looking statements due to a number of important factors, including uncertainty inherent in the clinical development and regulatory
United-states
American
Ultragenyx-hela
Cathryn-clary
Tim-palmer
Ilan-ganot
Carl-morris
Joel-schneider
Jennifer-green
Joseph-schwartz
Tim-palmer-corporate-communications
Solid-biosciences-inc